March 23, 2010 – The FDA granted approval for diltiazem hydrochloride extended-release tablets to treat ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 19, 2010 – An experimental factor Xa inhibitor given to patients with non-valvular atrial fibrillation (AF) ...
March 19, 2010
March 18, 2010 — New data from two subanalyses of the Treating to New Targets (TNT) trial showed an increased dose ...
March 18, 2010March 17, 2010 – New Results from PLATO trial suggest ticagrelor (Brilinta) leads to lower mortality and no ...
March 17, 2010March 16, 2010 — Lowering blood pressure to normal levels — below currently recommended levels — did not ...
March 17, 2010
Vytorin is a medicine used to lower levels of total cholesterol, LDL (bad) cholesterol, and fatty substances ...
March 10, 2010
Unlike the most common cholesterol-lowering medicines, statins, that work mainly in the liver, a new drug attempts ...
March 10, 2010
An FDA-approved, cholesterol-lowering medication has been proven to significantly reduce the risk of heart attack ...
March 10, 2010March 9, 2010 — An analysis of six tests that are used to measure platelet function and help gauge the ...
March 09, 2010March 3, 2010 – Pharmaceutical companies will struggle to profit from the cardiovascular disease (CVD) market over ...
March 03, 2010February 26, 2010 – The field of cardiovascular therapy is being transformed continuously due to the emergence of ...
February 26, 2010
February 25, 2010 – Recent clinical studies of Ranexa, a prescription medication used to treat adults with chronic ...
February 25, 2010February 23, 2010 – Experts in anti-platelet therapy will offer their insights and interpretations on emerging ...
February 23, 2010February 19, 2010 – A chemical compound found normally in the blood has shown promise in treating and preventing ...
February 19, 2010February 9, 2010 – The FDA approved CRESTOR (rosuvastatin calcium) to reduce the risk of stroke, myocardial ...
February 09, 2010© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now